Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FACTOR XIII CONCENTRATE for Haemorrhage prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where FACTOR XIII CONCENTRATE was used for Haemorrhage prophylaxis.

Most Reported Side Effects for FACTOR XIII CONCENTRATE

Side Effect Reports % Deaths Hosp.
Drug ineffective 25 16.1% 4 6
No adverse event 20 12.9% 0 0
Haemorrhage 12 7.7% 1 1
Device issue 9 5.8% 0 0
Off label use 8 5.2% 0 2
Product preparation issue 8 5.2% 0 0
Product use in unapproved indication 8 5.2% 1 0
Abortion spontaneous 7 4.5% 0 0
Exposure during pregnancy 7 4.5% 0 3
Factor xiii inhibition 7 4.5% 0 2
Deep vein thrombosis 5 3.2% 0 1
Drug ineffective for unapproved indication 5 3.2% 0 0
Dyspnoea 5 3.2% 0 3
Epistaxis 5 3.2% 0 0
Hypersensitivity 5 3.2% 0 1

Other Indications for FACTOR XIII CONCENTRATE

Factor xiii deficiency (57) Product used for unknown indication (19) Prophylaxis (18) Coagulation factor deficiency (9) Haemorrhage (6) Abnormal clotting factor (5)

Other Drugs Used for Haemorrhage prophylaxis

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (343) TRANEXAMIC ACID (207) ANTI-INHIBITOR COAGULANT COMPLEX (56) COAGULATION FACTOR IX RECOMBINANT HUMAN (52) PANTOPRAZOLE (48) EFANESOCTOCOG ALFA (42) EFTRENONACOG ALFA (34) EPINEPHRINE (26) EFMOROCTOCOG ALFA (22) CARBETOCIN (21)

Related Pages

FACTOR XIII CONCENTRATE Full Profile All Haemorrhage prophylaxis Drugs FACTOR XIII CONCENTRATE Demographics FACTOR XIII CONCENTRATE Timeline